Broxuridine

N/A

Report date: 2022/12/07 17:16:15
NME

Base Information

Drug NameBroxuridine
Drug Alias Namebroxuridinum溴脲苷溴尿苷broxuridine5-溴去氧尿苷 +[13] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionDNA modulators
TargetsDNA
Therapy Area/IndicationsProstatic NeoplasmsBrain NeoplasmsBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRush University Medical CenterInsys Therapeutics IncNeopharma Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsBrain NeoplasmsBreast Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksKEGG